Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Shanghai Henlius Biotech Yönetim
Yönetim kriter kontrolleri 2/4
Shanghai Henlius Biotech's CEO is Jason Zhu, appointed in Jul 2023, has a tenure of 1.25 years. total yearly compensation is CN¥9.26M, comprised of 87.8% salary and 12.2% bonuses, including company stock and options. directly owns 0.009% of the company’s shares, worth HK$1.13M. The average tenure of the management team and the board of directors is 2.2 years and 5.1 years respectively.
Anahtar bilgiler
Jason Zhu
İcra Kurulu Başkanı
CN¥9.3m
Toplam tazminat
CEO maaş yüzdesi | 87.8% |
CEO görev süresi | 1.3yrs |
CEO sahipliği | 0.009% |
Yönetim ortalama görev süresi | 2.2yrs |
Yönetim Kurulu ortalama görev süresi | 5.1yrs |
Son yönetim güncellemeleri
Recent updates
Is Shanghai Henlius Biotech (HKG:2696) Using Too Much Debt?
May 25Shanghai Henlius Biotech, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 25Shanghai Henlius Biotech, Inc.'s (HKG:2696) Price Is Right But Growth Is Lacking
Mar 10Here's Why Shanghai Henlius Biotech (HKG:2696) Is Weighed Down By Its Debt Load
Dec 31The Strong Earnings Posted By Shanghai Henlius Biotech (HKG:2696) Are A Good Indication Of The Strength Of The Business
Nov 25Is Shanghai Henlius Biotech (HKG:2696) Using Too Much Debt?
Sep 18Improved Revenues Required Before Shanghai Henlius Biotech, Inc. (HKG:2696) Shares Find Their Feet
Aug 03Shanghai Henlius Biotech (HKG:2696) Has Debt But No Earnings; Should You Worry?
May 31Need To Know: Analysts Are Much More Bullish On Shanghai Henlius Biotech, Inc. (HKG:2696) Revenues
Apr 06Is Shanghai Henlius Biotech (HKG:2696) Using Too Much Debt?
Sep 22CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Jun 30 2024 | n/a | n/a | CN¥692m |
Mar 31 2024 | n/a | n/a | CN¥619m |
Dec 31 2023 | CN¥9m | CN¥8m | CN¥546m |
Tazminat ve Piyasa: Jason's total compensation ($USD1.32M) is above average for companies of similar size in the Hong Kong market ($USD564.92K).
Tazminat ve Kazançlar: Insufficient data to compare Jason's compensation with company performance.
CEO
Jason Zhu (45 yo)
1.3yrs
Görev süresi
CN¥9,261,000
Tazminat
Dr. Jun Zhu, also known as Jason, had been Chief Financial Officer at Shanghai Henlius Biotech, Inc. since May 1, 2023 until July 1, 2024 and served as its President since November 30, 2021 until October 1...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Executive Chairman of the Board | 4.8yrs | CN¥12.58m | Veri yok | |
CEO & Executive Director | 1.3yrs | CN¥9.26m | 0.0092% CN¥ 1.1m | |
President | less than a year | Veri yok | Veri yok | |
Co-founder & Head of Strategy Advisory Committee | 14.7yrs | CN¥6.21m | 0.44% CN¥ 54.5m | |
Co-Founder & Co-Head of Innovative Advisory Committee | 14.7yrs | Veri yok | 0.13% CN¥ 16.3m | |
VP & CFO | less than a year | Veri yok | Veri yok | |
CTO & Senior VP | 1.8yrs | Veri yok | Veri yok | |
Vice President of Legal & Compliance Department | 1.8yrs | Veri yok | Veri yok | |
Deputy GM of Public Relations & Joint Company Secretary | 2.9yrs | Veri yok | Veri yok | |
VP of Sales & Oncology Business Unit | 4.8yrs | Veri yok | Veri yok | |
VP & Chief Human Resource Officer | 2.5yrs | Veri yok | Veri yok | |
Senior Vice President | no data | Veri yok | Veri yok |
2.2yrs
Ortalama Görev Süresi
52yo
Ortalama Yaş
Deneyimli Yönetim: 2696's management team is considered experienced (2.2 years average tenure).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Executive Chairman of the Board | 4.8yrs | CN¥12.58m | Veri yok | |
CEO & Executive Director | 1.2yrs | CN¥9.26m | 0.0092% CN¥ 1.1m | |
Independent Non-Executive Director | 5.1yrs | CN¥258.00k | Veri yok | |
Non-Executive Director | 11.8yrs | Veri yok | Veri yok | |
Independent Non-Executive Director | 5.1yrs | CN¥258.00k | Veri yok | |
Non-Executive Director | 5.8yrs | Veri yok | Veri yok | |
Member of Scientific Advisory Board | 1.3yrs | Veri yok | Veri yok | |
Non-Executive Director | 9.3yrs | Veri yok | Veri yok | |
Non-Executive Director | 2.3yrs | Veri yok | Veri yok | |
Independent Non-Executive Director | 5.1yrs | CN¥258.00k | Veri yok | |
Independent Non-Executive Director | 5.1yrs | CN¥258.00k | Veri yok | |
Chairman of Supervisory Board | 4.5yrs | Veri yok | Veri yok |
5.1yrs
Ortalama Görev Süresi
53yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 2696's board of directors are considered experienced (5.1 years average tenure).